Global Parkinson's Disease Treatments Market Growth (Status and Outlook) 2023-2029

Global Parkinson's Disease Treatments Market Growth (Status and Outlook) 2023-2029

Parkinson’s disease is a central nervous system syndrome which affects the motor neuron, mainly characterized by rigidity, tremor, depression, dementia, and so on. Treatment for this disease is mostly symptomatic and almost no curative treatment alternatives are available.

LPI (LP Information)' newest research report, the “Parkinson's Disease Treatments Industry Forecast” looks at past sales and reviews total world Parkinson's Disease Treatments sales in 2022, providing a comprehensive analysis by region and market sector of projected Parkinson's Disease Treatments sales for 2023 through 2029. With Parkinson's Disease Treatments sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Parkinson's Disease Treatments industry.

This Insight Report provides a comprehensive analysis of the global Parkinson's Disease Treatments landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Parkinson's Disease Treatments portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Parkinson's Disease Treatments market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Parkinson's Disease Treatments and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Parkinson's Disease Treatments.

The global Parkinson's Disease Treatments market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Parkinson's Disease Treatments is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Parkinson's Disease Treatments is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Parkinson's Disease Treatments is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Parkinson's Disease Treatments players cover GSK, Merck, Novartis, Teva, Boehringer Ingelheim, Impax, Abbvie, Bausch Health and Lundbeck, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Parkinson's Disease Treatments market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Dopamine Agonists
Levodopa
Glutamate Antagonist
Apomorphine
COMT Inhibitors Anticholinergics
MAO-B Inhibitors
Other Drugs

Segmentation by application
Hospitals
Healthcare Institutes
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
GSK
Merck
Novartis
Teva
Boehringer Ingelheim
Impax
Abbvie
Bausch Health
Lundbeck
Sun Pharma
Wockhardt
Acadia
UCB

Please note: The report will take approximately 2 business days to prepare and deliver.